Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voriconazole PK and Safety in Immunocompromised Children
NCT00739934Phase 2Completed
- Sponsor
- Pfizer
- Start
- Dec 2008
- Primary completion
- Oct 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of voriconazole in fungal infection, candidiasis, candidemia, sponsored by Pfizer. Started Dec 2008; status: completed.
02
Drugs
voriconazole
03
Conditions
fungal infectioncandidiasiscandidemia
Beyond the preview
Go deeper on NCT00739934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00739934.